Mandatory Medicaid Coverage of Routine Patient Costs Furnished in Connection with Participation in Qualifying Clinical Trials
Today, the Centers for Medicare & Medicaid Services (CMS) released a State Medicaid Director Letter (SMDL) that provides states and territories with information on changes to the Medicaid benefit package implemented by the Consolidated Appropriations Act, 2021 (CAA). The CAA added a new mandatory benefit for coverage of routine patient costs for services furnished in connection with participation by Medicaid beneficiaries in qualifying clinical trials, on or after January 1, 2022.
Final
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: December 07, 2021
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.